Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Specific Immunotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01350635
What this trial is testing

Skin Test Study of BM32

Who this might be right for
Hypersensitivity
Biomay AG 60
Testing effectiveness (Phase 2)Looking for participantsNCT04792489
What this trial is testing

DALY II USA/ MB-CART2019.1 for DLBCL

Who this might be right for
Refractory Diffuse Large B Cell Lymphoma (DLBCL)Relapsed Diffuse Large B Cell LymphomaHigh Grade B-cell Lymphoma (HGBCL)+6 more
Miltenyi Biomedicine GmbH 315
Early research (Phase 1)Ended earlyNCT02706405
What this trial is testing

JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Diffuse Large B-Cell LymphomaRecurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma+3 more
Fred Hutchinson Cancer Center 30
Early research (Phase 1)Study completedNCT02241369
What this trial is testing

Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies

Who this might be right for
Aerodigestive Precancerous Lesions and Malignancies
Inovio Pharmaceuticals 3
Testing effectiveness (Phase 2)Looking for participantsNCT06486051
What this trial is testing

Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell Lymphoma

Who this might be right for
Large B-cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPrimary Mediastinal Large B-cell Lymphoma (PMBCL)+1 more
Malaghan Institute of Medical Research 60
Early research (Phase 1)Study completedNCT02837094
What this trial is testing

Enhanced Epidermal Antigen Specific Immunotherapy Trial -1

Who this might be right for
Type 1 Diabetes
Cardiff University 6
Early research (Phase 1)Study completedNCT00008073
What this trial is testing

Octreotide and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of Pittsburgh
Testing effectiveness (Phase 2)Study completedNCT00133159
What this trial is testing

Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 68
Testing effectiveness (Phase 2)Study completedNCT02237196
What this trial is testing

Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy

Who this might be right for
Cat AllergyCat Hypersensitivity
National Institute of Allergy and Infectious Diseases (NIAID) 121
Not applicableUnknownNCT04405661
What this trial is testing

Correlation Between Specific Gene Mutationand Local Immune Microenvironment and Immunotherapy Efficacy in NSCLC

Who this might be right for
NSCLC
Guangzhou Institute of Respiratory Disease 100
Post-approval studies (Phase 4)UnknownNCT00496561
What this trial is testing

Effect of Specific Immunotherapy to Dust Mites in Children With Asthma

Who this might be right for
Asthma
Medical University of Lodz 80
Testing effectiveness (Phase 2)Study completedNCT00720031
What this trial is testing

Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones

Who this might be right for
Immunotherapy
Nantes University Hospital 16
Early research (Phase 1)Looking for participantsNCT03240328
What this trial is testing

The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function

Who this might be right for
HIV/AIDS
Guangzhou 8th People's Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT05773859
What this trial is testing

NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerOvarian Carcinoma
Radboud University Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00118625
What this trial is testing

Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 40
Testing effectiveness (Phase 2)Study completedNCT00258635
What this trial is testing

Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 69
Early research (Phase 1)Looking for participantsNCT04020575
What this trial is testing

Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

Who this might be right for
Metastatic Breast Cancer
Minerva Biotechnologies Corporation 69
Large-scale testing (Phase 3)Study completedNCT01353755
What this trial is testing

2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma

Who this might be right for
RhinoconjunctivitisAllergic Asthma
Allergopharma GmbH & Co. KG 195
Early research (Phase 1)Study completedNCT07317960
What this trial is testing

Phase I Study of PollenVax in Patients With Mugwort Pollen-Induced Allergic Rhinitis

Who this might be right for
Rhinitis Allergic
Kazakh National Agrarian University 30
Not applicableEnded earlyNCT03407040
What this trial is testing

Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy

Who this might be right for
Gastrointestinal CancersBreast CancerPancreatic Cancer+2 more
National Cancer Institute (NCI) 98
Next Page